Adjuvants For Viral Vaccines

Abstract

The present invention discloses mammalian vaccine compositions having an effective amount of an adjuvant, the adjuvant comprising squalene or squlane, glycerol and a surfactant. These compositions also optionally contain an aluminum salt and one or more pharmaceutically acceptable buffers.


Claims
Download PDF
Document Preview
Document History
  • Publication: Feb 17, 1998
  • Application: Jun 2, 1995
    US US 45960095 A
  • Priority: Jun 2, 1995
    US US 45960095 A

Download Citation


Sign in to the Lens

Feedback